Recruiting NA INTERVENTIONAL 7-arm NCT06770621

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (GLUREDIA)

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (GLUREDIA Study): Characteristics and Predictive Biomarkers.

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions Severe Hypoglycemia Type1diabetes

Interventions Biological sample once Glucagon profile Insulin-induced hypoglycemia test Observation-questionnaire

Updated 2 times since 2025 Last updated: Jan 7, 2025 Started: May 25, 2022 Primary completion: Oct 25, 2025 Completion: Oct 25, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06770621, this NA trial focuses on Severe Hypoglycemia and Type1diabetes and remains actively recruiting participants. Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain, it has been updated 2 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Feb 2025 — Sep 2025 [monthly]

Recruiting NA

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The Leona M. and Harry B. Helmsley Charitable Trust

Data source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium